173 related articles for article (PubMed ID: 21132428)
21. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
Front Immunol; 2020; 11():583382. PubMed ID: 33240271
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
23. In vivo compartmentalization of functionally distinct, rapidly responsive antigen-specific T-cell populations in DNA-immunized or Salmonella enterica serovar Typhimurium-infected mice.
Kirby AC; Sundquist M; Wick MJ
Infect Immun; 2004 Nov; 72(11):6390-400. PubMed ID: 15501769
[TBL] [Abstract][Full Text] [Related]
24. Tumor vaccination by Salmonella typhimurium after transformation with a eukaryotic expression vector in mice: impact of a Salmonella typhimurium gene interfering with MHC class I presentation.
Hummel S; Apte RN; Qimron U; Vitacolonna M; Porgador A; Zöller M
J Immunother; 2005; 28(5):467-79. PubMed ID: 16113603
[TBL] [Abstract][Full Text] [Related]
25. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
Nishikawa H; Sato E; Briones G; Chen LM; Matsuo M; Nagata Y; Ritter G; Jäger E; Nomura H; Kondo S; Tawara I; Kato T; Shiku H; Old LJ; Galán JE; Gnjatic S
J Clin Invest; 2006 Jul; 116(7):1946-54. PubMed ID: 16794737
[TBL] [Abstract][Full Text] [Related]
26. Induction of CD8+ T lymphocytes by Salmonella typhimurium is independent of Salmonella pathogenicity island 1-mediated host cell death.
Wijburg OL; Van Rooijen N; Strugnell RA
J Immunol; 2002 Sep; 169(6):3275-83. PubMed ID: 12218147
[TBL] [Abstract][Full Text] [Related]
27. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma.
Paglia P; Medina E; Arioli I; Guzman CA; Colombo MP
Blood; 1998 Nov; 92(9):3172-6. PubMed ID: 9787153
[TBL] [Abstract][Full Text] [Related]
28. Identification of Salmonella typhimurium genes responsible for interference with peptide presentation on MHC class I molecules: Deltayej Salmonella mutants induce superior CD8+ T-cell responses.
Qimron U; Madar N; Mittrücker HW; Zilka A; Yosef I; Bloushtain N; Kaufmann SH; Rosenshine I; Apte RN; Porgador A
Cell Microbiol; 2004 Nov; 6(11):1057-70. PubMed ID: 15469434
[TBL] [Abstract][Full Text] [Related]
29. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
30. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
[TBL] [Abstract][Full Text] [Related]
31. Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancer.
Burger UL; Chang MP; Goedegebuure PS; Eberlein TJ; Adams-Hodgins S
Surgery; 1995 Mar; 117(3):325-33. PubMed ID: 7878540
[TBL] [Abstract][Full Text] [Related]
32. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
[TBL] [Abstract][Full Text] [Related]
33. Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guérin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy.
Grode L; Kursar M; Fensterle J; Kaufmann SH; Hess J
J Immunol; 2002 Feb; 168(4):1869-76. PubMed ID: 11823521
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines.
Xu X; Husseiny MI; Goldwich A; Hensel M
Infect Immun; 2010 Nov; 78(11):4828-38. PubMed ID: 20732994
[TBL] [Abstract][Full Text] [Related]
35. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen.
Medina E; Paglia P; Rohde M; Colombo MP; Guzmán CA
Eur J Immunol; 2000 Mar; 30(3):768-77. PubMed ID: 10741391
[TBL] [Abstract][Full Text] [Related]
36. IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector.
Colombetti S; Lévy F; Chapatte L
Blood; 2009 Jun; 113(26):6629-37. PubMed ID: 19383968
[TBL] [Abstract][Full Text] [Related]
37. Recombinant
Deng W; Lira V; Hudson TE; Lemmens EE; Hanson WG; Flores R; Barajas G; Katibah GE; Desbien AL; Lauer P; Leong ML; Portnoy DA; Dubensky TW
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8179-8184. PubMed ID: 30038013
[TBL] [Abstract][Full Text] [Related]
38. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
[TBL] [Abstract][Full Text] [Related]
39. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
40. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model.
Espenschied J; Lamont J; Longmate J; Pendas S; Wang Z; Diamond DJ; Ellenhorn JD
J Immunol; 2003 Mar; 170(6):3401-7. PubMed ID: 12626601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
